# OnCo record aptevo-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/aptevo-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "aptevo-therapeutics" ;
  schema:name "Aptevo Therapeutics"@en ;
  schema:alternateName "Aptevo Therapeutics Inc."@en ;
  schema:description "Aptevo Therapeutics is a Seattle company that builds antibody-like proteins which point the immune system at cancer. Its lead medicine, mipletamig, links T cells to leukaemia cells and is being tested in newly diagnosed acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/aptevo-therapeutics/>, <https://www.aptevotherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1671584/000119312526361103/apvo-20260821.htm>, <https://www.aptevotherapeutics.com/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd123/>, <https://onco.cc/targets/cd3/>, <https://onco.cc/targets/cd137/> ;
  onco:drugs <https://onco.cc/drugs/mipletamig/>, <https://onco.cc/drugs/alg-apv-527/> .